Skip to content
PubMed This is a summary of 53 peer-reviewed journal articles Updated
Pediatrics · Glycogen Storage Disease Type Ia

Understanding Your Child's GSD Ia Diagnosis

At a Glance

Glycogen Storage Disease Type Ia (GSD Ia) is a rare genetic disorder where the liver cannot release stored sugar, causing dangerously low blood sugar. It is managed with a strict, 24/7 feeding routine to keep blood sugar levels stable, allowing diagnosed children to grow, learn, and thrive.

The news that your child has Glycogen Storage Disease Type Ia (GSD Ia), also known as Von Gierke disease, can feel like the world has shifted beneath your feet. It is a rare, complex diagnosis that immediately demands a level of precision and vigilance that most parents never have to consider [1]. While the initial period after diagnosis is often overwhelming, it is important to know that you are now part of a community that has navigated this path before.

Three Stabilizing Facts

In the midst of this new reality, these three facts can help provide a foundation as you move forward:

  1. GSD Ia is a known, well-defined genetic disorder: Doctors understand exactly why it happens and how it affects the body [2][3].
  2. Strict routine is the most powerful tool: While there is currently no cure, the primary way to manage GSD Ia is through a precise, strict feeding routine [4][5].
  3. It is manageable: With a dedicated care team and a consistent routine, children with GSD Ia can grow, learn, and thrive [1].

Why the Body Struggles to Release Sugar

To understand GSD Ia, it helps to think of the liver as a battery for the body’s energy. Normally, when we eat, our body stores extra sugar (glucose) in the liver as glycogen (a complex chain of sugars). When we stop eating—such as during sleep—the liver is supposed to break that glycogen back down into glucose to keep our blood sugar levels steady.

In GSD Ia, the body is missing an enzyme called glucose-6-phosphatase (G6Pase) [2][6]. This enzyme acts like a “key” that unlocks the stored sugar. Without it, the “battery” is full of energy (glycogen), but the “door” is locked. The sugar stays trapped in the liver, and the blood sugar levels drop dangerously low, a condition called hypoglycemia [2][3]. Because the sugar is trapped, it can also cause the liver to become enlarged (hepatomegaly) [7][5].

The Genetic Connection and “Founder Effects”

GSD Ia is an autosomal recessive genetic condition, meaning a child must inherit one copy of the mutated gene from each parent. In certain populations, specific mutations are more common due to what is called a founder effect—when a small group of ancestors carries a specific genetic trait that becomes more prevalent in their descendants over generations.

  • Ashkenazi Jewish Population: A specific mutation known as R83C is a common “founder variant” in this community [8].
  • Korean Population: A mutation known as c.648G>T is highly prevalent and considered a founder mutation in the Korean population [9][10].

The Reality of Caregiver Life

The burden of GSD Ia management is significant, especially in the early days. The need for 24/7 care—including middle-of-the-night feedings or cornstarch doses—can lead to profound sleep deprivation and “caregiver burnout” [11][1]. It is normal to feel anxious about the risk of hypoglycemia.

Many families eventually use tools like Continuous Glucose Monitors (CGM) to help monitor sugar levels and provide an extra layer of safety [12]. While the routine is intense, many parents find that over time, the “new normal” becomes a manageable part of family life [1]. Connecting with patient advocacy groups (such as the Association for Glycogen Storage Disease) can provide invaluable peer support and daily practical management tips. Your primary goal right now is metabolic stability: keeping your child’s “battery” topped up through frequent, scheduled feedings [4][13].

Navigating This Guide

This resource is designed to help you understand and manage your child’s diagnosis. Please explore the pages below to learn more about specific aspects of GSD Ia:

Common questions in this guide

What exactly causes GSD Ia?
GSD Ia is caused by the lack of an enzyme called glucose-6-phosphatase (G6Pase). Without this enzyme, your child's liver can store sugar but cannot release it back into the bloodstream, which leads to dangerously low blood sugar levels when they stop eating.
How is Glycogen Storage Disease Type Ia treated?
While there is currently no cure, GSD Ia is highly manageable through a strict, consistent feeding routine. This often involves specific scheduled feedings, including middle-of-the-night meals or cornstarch doses, to keep the body's energy levels stable.
Is GSD Ia an inherited condition?
GSD Ia is an autosomal recessive genetic condition, meaning a child inherits one mutated gene from each parent. Certain communities, such as Ashkenazi Jewish and Korean populations, have a higher chance of carrying these mutations due to a 'founder effect'.
Can a continuous glucose monitor (CGM) help manage my child's GSD Ia?
Yes, many families use a continuous glucose monitor to track their child's blood sugar levels around the clock. This device provides an extra layer of safety and can alert you to dangerous drops in blood sugar overnight, helping to prevent emergencies.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is our child's specific fasting tolerance right now, and how will we know when it's safe to increase the time between feedings?
  2. 2.Can you explain our child's specific genetic mutation and if it is associated with a 'founder effect' in our ethnic background?
  3. 3.How do we access 24/7 emergency support if we encounter a problem with a feeding or a suspected hypoglycemic event?
  4. 4.What tools, such as Continuous Glucose Monitors (CGM), can we use to help us monitor sugar levels overnight?
  5. 5.Are there local or national support groups you recommend for parents specifically managing GSD Ia?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Impact of glycogen storage disease type I on adult daily life: a survey.

    Garbade SF, Ederer V, Burgard P, et al.

    Orphanet journal of rare diseases 2021; (16(1)):371 doi:10.1186/s13023-021-02006-w.

    PMID: 34479584
  2. 2

    Efficacious genome editing in infant mice with glycogen storage disease type Ia.

    Arnson B, Ilich E, von Beck T, et al.

    JCI insight 2025; (10(18)).

    PMID: 40762955
  3. 3

    Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia.

    Arnson B, Kang HR, Brooks ED, et al.

    Molecular therapy. Methods & clinical development 2023; (29()):108-119 doi:10.1016/j.omtm.2023.03.001.

    PMID: 37021039
  4. 4

    A case study of glycogen storage disease type Ia presenting with multiple hepatocellular adenomas: an analysis by gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid magnetic resonance imaging.

    Li X, Jing H, Cheng L, et al.

    Quantitative imaging in medicine and surgery 2021; (11(6)):2785-2791 doi:10.21037/qims-20-746.

    PMID: 34079743
  5. 5

    A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report.

    Wang W, Yu R, Tan W, et al.

    BMC medical genetics 2019; (20(1)):85 doi:10.1186/s12881-019-0816-9.

    PMID: 31109299
  6. 6

    Glucose-6 Phosphate, A Central Hub for Liver Carbohydrate Metabolism.

    Rajas F, Gautier-Stein A, Mithieux G

    Metabolites 2019; (9(12)) doi:10.3390/metabo9120282.

    PMID: 31756997
  7. 7

    Clinical features of gout in adult patients with type Ia glycogen storage disease: a single-centre retrospective study and a review of literature.

    Xu N, Han X, Zhang Y, et al.

    Arthritis research & therapy 2022; (24(1)):58 doi:10.1186/s13075-021-02706-5.

    PMID: 35219330
  8. 8

    Clinical, laboratory and molecular features of glycogen storage disease type 1a and 1b patients from Turkey: novel mutations and phenotypes.

    Akyüz A, Okur İ, Tümer L, et al.

    European journal of pediatrics 2025; (184(9)):540.

    PMID: 40781175
  9. 9

    Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.

    Kim YM, Choi JH, Lee BH, et al.

    Orphanet journal of rare diseases 2020; (15(1)):45 doi:10.1186/s13023-020-1321-0.

    PMID: 32046761
  10. 10

    Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases.

    Liang Y, Du C, Wei H, et al.

    Molecular genetics & genomic medicine 2020; (8(10)):e1444 doi:10.1002/mgg3.1444.

    PMID: 32772503
  11. 11

    Sleep and quality of life of patients with glycogen storage disease on standard and modified uncooked cornstarch.

    Rousseau-Nepton I, Huot C, Laforte D, et al.

    Molecular genetics and metabolism 2018; (123(3)):326-330 doi:10.1016/j.ymgme.2017.09.003.

    PMID: 29223626
  12. 12

    Type la glycogen storage disease complicated with diabetes mellitus: the role of flash continuous glucose monitoring.

    Marcalo J, Oliveira A, Nunes PA, do Vale S

    BMJ case reports 2021; (14(3)) doi:10.1136/bcr-2020-240489.

    PMID: 33766968
  13. 13

    Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.

    Hijmans BS, Boss A, van Dijk TH, et al.

    Hepatology (Baltimore, Md.) 2017; (66(6)):2042-2054 doi:10.1002/hep.29389.

    PMID: 28727166

This page provides educational information about GSD Ia for parents and caregivers. Always consult your pediatric metabolic specialist or endocrinologist before making any changes to your child's feeding routine or medical care.

Get notified when new evidence is published on Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.